Latest Breaking News On - Yvonne massar - Page 1 : comparemela.com

Presentation and webcast to take place at: 07:30 AM EST on January 14 NIJMEGEN, The Netherlands, January 11, 2021 / B3C newswire / Byondis, a clinical-stage biopharmaceutical company today announced that its Chief Executive Officer, Marco Timmers, Ph.D., will present at the J.P. Morgan Healthcare Conference at 07:30 AM EST / 01:30 PM Central European Time (CET) on Thursday, January 14, 2021.  A link to the live audio webcast of this presentation will be available on the Events Calendar of www.byondis.com. A replay will also be available on the Byondis website following the presentation.   Driven to improve patients’ lives, Byondis is an independent clinical-stage biopharmaceutical company creating innovative precision medicines targeting intractable cancers and autoimmune diseases. The company is developing new biological entities (NBEs) and new chemical entities (NCEs) and differentiates itself from other biopharmaceutical companies by its proprietary molecular concepts, su

Marco timmersYvonne massarPublic eyes healthcare communicationsCorporate communicationsChief executive officerHealthcare conferenceEuropean timeEvents calendarAutoimmune diseasesJp morgan healthcare conferenceNew biological entities nbesNew chemical entitiesTrastuzumab duocarmycinsமார்கோ டைமர்கள்ய்வாந் மசார்பொது கண்கள் சுகாதாரம் தகவல்தொடர்புகள்